Trillium Therapeutics Inc. 3 SEC Filings

Filed On	Filing
02 Jul 2021	Form 3: Mackey Catherine J, Director No securities owned
05 May 2021	Form 3: Looker Benjamin, General Counsel No securities owned
05 May 2021	Form 3: Myers Scott Dunseth, Director No securities owned
04 Jan 2021	Form 3: Pucci Paolo, Director
04 Jan 2021	Form 3: Beshar Luke M, Director
04 Jan 2021	Form 3: Parsons James T., Chief Financial Officer
04 Jan 2021	Form 3: Reynolds Thomas C, Director
04 Jan 2021	Form 3: Harrison Rosemary, See Remarks Holds 75 shares of Common Shares
04 Jan 2021	Form 3: Uger Robert, Chief Scientific Officer
04 Jan 2021	Form 3: Walker Paul Edward, Director Holds 5,736,363 shares of Common Shares
04 Jan 2021	Form 3: Kirkman Robert L, Director
04 Jan 2021	Form 3: Petrova Penka, Chief Development Officer
04 Jan 2021	Form 3: Kamarck Michael E., Director
04 Jan 2021	Form 3: Skvarka Jan, Director
04 Jan 2021	Form 3: Bruns Ingmar, Chief Medical Officer
04 Jan 2021	Form 3: Tayton-martin Helen Katrina, Director

Comments